Sanofi Drug For Further Processing
NDC Database

Sanofi Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 3
  • Latest Marketing Date 2025-03-28
  • Data Source FDA
  • First Marketing Date 2025-02-14
All
5
View
Bulk Ingredient
2
View
Drug for Further Processing
3
View
Company Overview

Company

Sanofi Drug For Further Processing

Country

France

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Sanofi Drug For Further Processing

54, rue La Boetie 75008 Paris

France

www.sanofi.com/en/your-health/specialty-care View on Map
NDC Records ( 3 records )
2025
14 Feb
Drug for Further Processing NDC: 12854-050

Nonproprietary Name

insulin aspart-szjj

Dosage Form

INJECTION, SOLUTION

Strength

100 [iU]/mL

Labeler

Sanofi-Aventis Deutschland GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

12854-050

Substance

INSULIN ASPART

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-02-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
14 Feb
Drug for Further Processing NDC: 12854-060

Nonproprietary Name

insulin aspart-szjj

Dosage Form

INJECTION, SOLUTION

Strength

100 [iU]/mL

Labeler

Sanofi-Aventis Deutschland GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

12854-060

Substance

INSULIN ASPART

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-02-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
28 Mar
Drug for Further Processing NDC: 12854-310

Nonproprietary Name

fitusiran

Dosage Form

INJECTION, SOLUTION

Strength

50 mg/.5mL

Labeler

Sanofi-Aventis Deutschland GmbH

Marketing Category

DRUG FOR FURTHER PROCESSING

12854-310

Substance

FITUSIRAN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-03-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    16 View
  • EDQM CEP
    45 View
  • KDMF
    0 View
  • Japan DMF
    2 View
  • Eudra GMP
    0 View
  • NDC Database
    5 View
  • FDA Approved Drugs Database
    11 View
NDC Type Breakdown
3 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

12854-050

Nonproprietary Name

insulin aspart-szjj

Labeler

Sanofi-Aventis Deutschland GmbH

Dosage Form

INJECTION, SOLUTION

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.